Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers
PI3K 和 MEK 抑制剂联合使用可在 PIK3CA 突变化生性乳腺癌的 PDX 模型中实现持久缓解
期刊:Journal of Hematology & Oncology
影响因子:29.5
doi:10.1186/s13045-020-0846-y
F Coussy, R El Botty, M Lavigne, C Gu, L Fuhrmann, A Briaux, L de Koning, A Dahmani, E Montaudon, L Morisset, L Huguet, L Sourd, P Painsec, S Chateau-Joubert, T Larcher, S Vacher, S Melaabi, A Vincent Salomon, E Marangoni, I Bieche
